EGFR
Les inhibiteurs du récepteur du facteur de croissance épidermique (EGFR) sont des composés qui bloquent la signalisation de l'EGFR, un récepteur souvent surexprimé dans divers cancers et qui joue un rôle crucial dans l'angiogenèse. Les inhibiteurs de l'EGFR sont utilisés pour prévenir la croissance tumorale et les métastases en perturbant les voies qui favorisent la formation de vaisseaux sanguins dans les tumeurs. Ces inhibiteurs sont largement utilisés dans la recherche et le traitement du cancer. Chez CymitQuimica, nous offrons une sélection diversifiée d'inhibiteurs de l'EGFR de haute qualité pour soutenir vos recherches en oncologie et angiogenèse.
Produits appartenant à la catégorie "EGFR"
Trier par
EGFR-IN-86
EGFR-IN-86 (compound 4i), an EGFR inhibitor (IC50: 1.5 nM), demonstrates potent activity against glioblastoma by inducing apoptosis and causing G2/M phase cellFormule :C20H21N7O2SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :423.49Becotatug
CAS :Becotatug (JMT-101) is an IgG1 antibody that targets EGFR and can be conjugated to Afatinib and Osimertinib, functioning as a synthetic antibody-drug conjugateDegré de pureté :98%Couleur et forme :LiquidPertuzumab
CAS :Pertuzumab (anti-HER2) a humanized monoclonal antibody and the first in the class of agents called the HER2 dimerization inhibitors impairs the ability of HER2Degré de pureté :98.00%Couleur et forme :LiquidMasse moléculaire :148 kDaEGFR-IN-83
EGFR-IN-83 (Compound 9), an EGFR inhibitor with an IC50 of 2.53 nM, exhibits antiproliferative effects on MCF-7 and MDA-MB-231 cell lines, with respective IC50Formule :C22H17F3N4ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :410.39O-Desmethyl gefitinib
CAS :O-Desmethyl gefitinib is an active EGFR inhibitor (IC50: 36 nM), a metabolite of Gefitinib, formed by CYP2D6.Formule :C21H22ClFN4O3Degré de pureté :97.17%Couleur et forme :SolidMasse moléculaire :432.88Ref: TM-T16369
1mg56,00€5mg111,00€10mg170,00€25mg343,00€50mg547,00€100mg783,00€1mL*10mM (DMSO)120,00€Befotertinib
CAS :Befotertinib (D-0316) is an inhibitor of EGFR tyrosine kinase and can be used for studies about EGFR T790M-positive non-small cell lung cancer.Formule :C29H32F3N7O2Degré de pureté :99.40%Couleur et forme :SolidMasse moléculaire :567.61Ref: TM-T39275
1mg88,00€5mg187,00€10mg298,00€25mg525,00€50mg747,00€100mg1.026,00€1mL*10mM (DMSO)235,00€EGFR-IN-124
EGFR-IN-124 (compound 10A) is an EGFR inhibitor with an IC50 value of 0.54 μM, utilized in cancer research.Couleur et forme :Odour SolidEAI045
CAS :EAI045, an allosteric inhibitor, targets towards drug-resistant EGFR mutants but avoids the wild-type receptor.Formule :C19H14FN3O3SDegré de pureté :98.00% - 99.73%Couleur et forme :SolidMasse moléculaire :383.4Multi-target kinase inhibitor 2
Compound 5K (Multi-target kinase inhibitor 2) is a multi-targeted kinase inhibitor demonstrating activity against EGFR, Her2, VEGFR2, and CDK2 with IC50 valuesDegré de pureté :98%Couleur et forme :Odour SolidSimotinib
CAS :Simotinib (AL-6802) is an EGFR tyrosine kinase inhibitor (IC50 : 19.9 nM) with antitumour activity for the study of non-small cell lung cancer.Formule :C25H26ClFN4O4Degré de pureté :99.7%Couleur et forme :SolidMasse moléculaire :500.95AZ-5104
CAS :AZ5104 is a potent EGFR inhibitor.Formule :C27H31N7O2Degré de pureté :98.40% - 99.9%Couleur et forme :Solid PowderMasse moléculaire :485.58EGFR-IN-85
CAS :EGFR-IN-85 (Compound 1), an EGFR inhibitor, exhibits potent activity with an IC50 of 0.19 μM against EGFRvⅢ phosphorylation and can suppress intratumoral EGFRFormule :C26H30N8O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :486.57Theliatinib
CAS :Theliatinib: potent, selective EGFR inhibitor, anti-tumor; Ki=0.05 nM (EGFR), IC50=3 nM (EGFR), 22 nM (T790M/L858R).Formule :C25H26N6O2Degré de pureté :99.67%Couleur et forme :SolidMasse moléculaire :442.51EGFR/ErbB-2/ErbB-4 inhibitor-2
CAS :EGFR/ErbB-2/ErbB-4 inhibitor-2 (EGFR/ErbB2 Inhibitor) is a cell-permeable inhibitor of EGFR and c-ErbB2 (IC50s = 20 and 79 nM, respectively)Formule :C23H21N3O3Degré de pureté :99.55%Couleur et forme :SolidMasse moléculaire :387.43Ref: TM-T21954
1mg75,00€2mg94,00€5mg140,00€10mg205,00€25mg371,00€50mg557,00€100mg810,00€200mg1.074,00€1mL*10mM (DMSO)157,00€TYRPHOSTIN RG 14620
CAS :Formule :C14H8Cl2N2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :275.13272EGFRVIII Protein, Human, Recombinant (His & Avi)
The epidermal growth factor receptor (EGFR) is overexpressed in a variety of human epithelial tumors, often as a consequence of gene amplification.Couleur et forme :Lyophilized PowderMasse moléculaire :41.6 kDa (predicted). Due to glycosylation, the protein migrates to 68-80 kDa based on Tris-Bis PAGE result.YH32367
YH32367 (ABL105) is a bispecific antibody targeting HER2 and 4-1BB. It induces the secretion of IFN-γ, resulting in the death of tumor cells when co-cultured with hPBMC and HER2-expressing tumor cells. YH32367 demonstrates notable antitumor activity.Couleur et forme :Odour LiquidDuligotuzumab
CAS :Duligotuzumab (MEHD-7945A; RG 7597) is a humanized IgG-κ monoclonal antibody targeting Her3 (ErbB3) [1].Degré de pureté :98%Couleur et forme :LiquidARRY-380 (analog )
CAS :ARRY-380 analog (HER2-Inhibitor-1) is a potent and selective HER2 inhibitor.Formule :C29H27N7O4SDegré de pureté :98.22%Couleur et forme :SolidMasse moléculaire :569.63Ref: TM-T2518
1mg35,00€2mg49,00€5mg74,00€10mg110,00€25mg180,00€50mg266,00€100mgÀ demander1mL*10mM (DMSO)96,00€LY 456236 hydrochloride
CAS :LY 456236 hydrochloride (MPMQ hydrochloride) is an mGlu1 receptor antagonist with an ic50 value of 143 nM.Formule :C16H16ClN3O2Degré de pureté :99.89%Couleur et forme :SolidMasse moléculaire :317.77AG 1478 Hydrochloride
CAS :Formule :C16H14ClN3O2·HClDegré de pureté :>95.0%(T)(HPLC)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :352.22EGFR/VEGFR2-IN-2
EGFR/VEGFR2-IN-2 (compound 4b) serves as a dual inhibitor of VEGFR-2 and EGFR.Formule :C24H15FO3Couleur et forme :SolidMasse moléculaire :370.37EGFR-IN-79
EGFR-IN-79 (compound 21), an EGFR inhibitor, exhibits antitumor activity through ROS-independent apoptosis and EGFR/AKT/mTOR-mediated autophagy.Formule :C23H16ClN3O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :417.84lavendustin C
CAS :lavendustin C (NSC 666251) is a potent inhibitor of epidermal growth factor (EGF) receptor-associated tyrosine kinase.Formule :C14H13NO5Degré de pureté :97.77%Couleur et forme :Yellow To Tan PowderMasse moléculaire :275.26Ref: TM-T4185
1mg44,00€2mg58,00€5mg87,00€10mg160,00€25mg349,00€50mg518,00€100mg747,00€1mL*10mM (DMSO)95,00€Amivantamab
CAS :Amivantamab (JNJ-61186372) is an antibody that recognizes EGFR and MET and has anticancer and antitumor activities.Degré de pureté :97.24% (SEC-HPLC) - 99.74%Couleur et forme :LiquidMasse moléculaire :145.88 kDaEGFR-IN-2
CAS :EGFR-IN-2 is a non-covalent, mutation-selective and irreversible second-generation EGFR inhibitor.Formule :C26H33N9O3SDegré de pureté :100%Couleur et forme :SolidMasse moléculaire :551.66EGFR/CSC-IN-1
CAS :EGFR/CSC-IN-1 is a dual inhibitor targeting both the epidermal growth factor receptor (EGFR [IC50 10.52 nM]) and cancer stem cells (CSC), with potentialFormule :C54H54Cl2FN7O7S2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :1067.08EGFR-IN-135
EGFR-IN-135 (compound 3d) is an EGFR inhibitor with an IC50 value of 0.086 µM. It inhibits cell growth and arrests the cell cycle in the S phase in breast cancer cell lines.Formule :C12H14N4OS2Couleur et forme :SolidMasse moléculaire :294.4G5-7
CAS :G5-7 is an oral JAK2 inhibitor targeting EGFR/STAT3 phosphorylation with potential for glioma research.Formule :C22H19F2NO3Degré de pureté :97.30%Couleur et forme :SolidMasse moléculaire :383.39Ref: TM-T8742
1mg50,00€5mg97,00€10mg145,00€25mg259,00€50mg374,00€100mg523,00€200mg710,00€1mL*10mM (DMSO)105,00€Avitinib maleate
CAS :Avitinib maleate is a pyrrolopyrimidine-based irreversible epidermal growth factor receptor (EGFR) inhibitor.Formule :C30H30FN7O6Degré de pureté :98% - 99.74%Couleur et forme :SolidMasse moléculaire :603.61EGFR/VEGFR2-IN-5
EGFR/VEGFR2-IN-5 (Compound 14) is an orally active dual inhibitor of EGFR and VEGFR2, exhibiting an IC50 value of 1.15 µM for VEGFR2 and 0.28 µM for EGFRT790M. This compound demonstrates significant anticancer activity.Formule :C17H15N7O5SCouleur et forme :SolidMasse moléculaire :429.41EGFR-IN-136
EGFR-IN-136 (compound 21v) is a potent inhibitor of EGFR, demonstrating IC50 values of 20.2 nM, 1.2 nM, 2.3 nM, and 12.5 nM for EGFRWT, EGFRLR/TM, EGFR19D/TM/CS, and EGFRLR/TM/CS, respectively. It exhibits antiproliferative and antitumor activities and holds potential for research in non-small cell lung cancer (NSCLC).Formule :C30H36N7O4PMasse moléculaire :589.625Cetuximab MMAE
Cetuximab-MMAE, an antibody-drug conjugate (ADC), combines an EGFR-targeting antibody with Monomethyl auristatin E (MMAE) to investigate colorectal and head and neck cancers.Couleur et forme :LiquidMasse moléculaire :150 kDaTyrphostin AG528
CAS :Formule :C18H14N2O3Degré de pureté :>97.0%(HPLC)Couleur et forme :Light yellow to Amber to Dark green powder to crystalMasse moléculaire :306.32Rociletinib
CAS :Rociletinib (CNX-419) is an orally available small molecule, irreversible inhibitor of epidermal growth factor receptor (EGFR) with potential antineoplasticFormule :C27H28F3N7O3Degré de pureté :98.39% - 99.25%Couleur et forme :SolidMasse moléculaire :555.55CNX-2006
CAS :CNX-2006 is a novel irreversible mutant-selective EGFR inhibitor with IC50 of < 20 nM, with very weak inhibition at wild-type EGFR.Formule :C26H27F4N7O2Degré de pureté :98.85% - 99.16%Couleur et forme :SolidMasse moléculaire :545.53Brivanib
CAS :Brivanib (BMS-540215) is an ATP-competitive inhibitor against VEGFR2 with IC50 of 25 nM, moderate potency against VEGFR-1 and FGFR-1, but >240-fold againstFormule :C19H19FN4O3Degré de pureté :98.87%Couleur et forme :SolidMasse moléculaire :370.38Ref: TM-T6036
1mg47,00€5mg88,00€10mg144,00€25mg259,00€50mg375,00€100mg560,00€200mg815,00€1mL*10mM (DMSO)97,00€NRC-2694
CAS :NRC-2694 is an antagonist of the epidermal growth factor receptor (EGFR). It has anti-cancer and anti-proliferative properties.Formule :C24H26N4O3Degré de pureté :99.38%Couleur et forme :SolidMasse moléculaire :418.49Ref: TM-T16343
1mg85,00€5mg160,00€10mg250,00€25mg424,00€50mg562,00€100mg810,00€200mg1.074,00€1mL*10mM (DMSO)170,00€Tyrphostin A25
CAS :Tyrphostin A25 (Tyrphostin AG 82) is a specific EGFR tyrosine kinase inhibitor and GPR35 agonist with an IC50 value of 0.94 μM for GPR35 and an EC50 value of 5.Formule :C10H6N2O3Degré de pureté :98.76%Couleur et forme :Yellow Green Powder /Off-White SolidMasse moléculaire :202.17SHR-A1201
SHR-A1201 is an antibody-drug conjugate (ADC) targeting HER2. This compound is composed of a humanized anti-HER2 antibody, the linker SMCC, and the cytotoxic payload Mertansine, which is a microtubule inhibitor. SHR-A1201 is utilized in research for HER2-positive breast cancer.Formule :C50H63ClF3N5O12Couleur et forme :LiquidMasse moléculaire :1018.51MTX-241F
MTX-241F, a selective small molecule inhibitor, targets members of the EGFR and PI3 kinase families.Formule :C20H14ClFN6Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :392.82Tyrphostin 23
CAS :Tyrphostin 23 (AG18) inhibits EGFR with IC50 of 35 μM.Formule :C10H6N2O2Degré de pureté :99.19% - 99.7%Couleur et forme :Yellow-Tan SolidMasse moléculaire :186.17Tarlox-TKI
CAS :Tarlox-TKI (Kinase inhibitor-1) is a pan-ErbB inhibitor, the active ingredient of Tarloxotinib, which has antitumor activity.Formule :C19H18BrClN6ODegré de pureté :97.03%Couleur et forme :SolidMasse moléculaire :461.74Olmutinib
CAS :Olmutinib is an oral mutant-specific EGFR inhibitor for cancer treatment with potential lower toxicity.Formule :C26H26N6O2SDegré de pureté :99.63%Couleur et forme :SolidMasse moléculaire :486.59Ref: TM-T6918
2mg39,00€5mg57,00€10mg88,00€25mg137,00€50mg180,00€100mg283,00€200mg462,00€1mL*10mM (DMSO)59,00€Almonertinib hydrochloride
CAS :Almonertinib hydrochloride (HS-10296 hydrochloride) is a small molecule inhibitor of EGFR-activating mutations and T790M-resistant mutation.Formule :C30H36ClN7O2Degré de pureté :98.01% - 98.12%Couleur et forme :SolidMasse moléculaire :562.12′-Thioadenosine
CAS :2'-Thioadenosine (PD157432) serves as a selective and irreversible inhibitor of ErbB-1 and ErbB-2 tyrosine kinases, demonstrating an IC50 value of 45 µM againstFormule :C10H13N5O3SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :283.31EGFRVIII Protein, Human, Recombinant (His & Avi), PE-Labeled
The epidermal growth factor receptor (EGFR) is overexpressed in a variety of human epithelial tumors, often as a consequence of gene amplification.Couleur et forme :Lyophilized PowderMasse moléculaire :41.6 kDa (predicted)BI-4732
CAS :DL-Homocystine is a mutagen secreted by F. nucleatum.Formule :C32H36N10O2Degré de pureté :98.88%Couleur et forme :SolidMasse moléculaire :592.69Olmutinib
CAS :Olmutinib (BI1482694) is a Novel Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorFormule :C26H26N6O2SDegré de pureté :99.14%Couleur et forme :SolidMasse moléculaire :486.59Ref: TM-T8460
2mg35,00€5mg57,00€10mg93,00€25mg131,00€50mg185,00€100mg283,00€200mg464,00€1mL*10mM (DMSO)63,00€AEE788
CAS :AEE788 (NVP-AEE 788) has been used in trials studying the treatment of Cancer, Glioblastoma Multiforme, and Brain and Central Nervous System Tumors.Formule :C27H32N6Degré de pureté :100% - 98.94%Couleur et forme :SolidMasse moléculaire :440.58Ref: TM-T2116
2mg47,00€5mg70,00€10mg103,00€25mg188,00€50mg325,00€100mg490,00€500mg1.103,00€1mL*10mM (DMSO)77,00€
